Indication
Asthma
Asthma is a common, chronic inflammatory disease of the lower respiratory system characterized by recurrent episodes of airway hyperresponsiveness, mucosal edema, mucus hypersecretion, and variable, often reversible airflow obstruction. Read more about Asthma
0 drugs 0 manufacturers
Drugs that treat it
Common Asthma therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAsthma is a common, chronic inflammatory disease of the lower respiratory system characterized by recurrent episodes of airway hyperresponsiveness, mucosal edema, mucus hypersecretion, and variable, often reversible airflow obstruction.
It affects diverse pediatric and adult populations worldwide and involves complex gene-environment interactions that trigger inflammation via eosinophilic, allergic, or non-allergic pathways.
Clinically, affected individuals experience paroxysmal or fluctuating symptoms including wheezing, dyspnea, chest tightness, and cough, which frequently worsen at night, during exercise, or upon exposure to environmental allergens, irritants, or viral respiratory infections.
Chronic airway inflammation can lead to progressive structural airway remodeling and severe, potentially life-threatening acute exacerbations.
- nih.gov
Asthma is a common, chronic inflammatory disease of the lower respiratory system characterized by recurrent episodes of airway hyperresponsiveness, mucosal edema, mucus hypersecretion, and variable, often reversible airflow obstruction It affects diverse pediatric and adult populations worldwide and involves complex gene-environment interactions that trigger inflammation via eosinophilic, allergic, or non-allergic pathways Clinically, affected individuals experience paroxysmal or fluctuating sym...
- nih.gov
Asthma is a common, chronic inflammatory disease of the lower respiratory system characterized by recurrent episodes of airway hyperresponsiveness, mucosal edema, mucus hypersecretion, and variable, often reversible airflow obstruction
- nih.gov
It affects diverse pediatric and adult populations worldwide and involves complex gene-environment interactions that trigger inflammation via eosinophilic, allergic, or non-allergic pathways
- nih.gov
It affects diverse pediatric and adult populations worldwide and involves complex gene-environment interactions that trigger inflammation via eosinophilic, allergic, or non-allergic pathways Chronic airway inflammation can lead to progressive structural airway remodeling and severe, potentially life-threatening acute exacerbations
- nih.gov
Clinically, affected individuals experience paroxysmal or fluctuating symptoms including wheezing, dyspnea, chest tightness, and cough, which frequently worsen at night, during exercise, or upon exposure to environmental allergens, irritants, or viral respiratory infections
- nih.gov
Clinically, affected individuals experience paroxysmal or fluctuating symptoms including wheezing, dyspnea, chest tightness, and cough, which frequently worsen at night, during exercise, or upon exposure to environmental allergens, irritants, or viral respiratory infections
- nih.gov
Chronic airway inflammation can lead to progressive structural airway remodeling and severe, potentially life-threatening acute exacerbations
- nih.gov
Chronic airway inflammation can lead to progressive structural airway remodeling and severe, potentially life-threatening acute exacerbations
Personalize your experience
Follow Asthma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.